Zealand Pharma Announces Financial Results for the First Nine Months of 2025 With petrelintide advancing at full speed and topline data rapidly approaching for both petrelintide and survodutide, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback